We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Section 61(5A) of the Therapeutic Goods Act 1989 provides that the Secretary may release to the public therapeutic goods information relating to any decision or action taken under this Act or the regulations. It is TGA practice to publish details of regulatory compliance decisions and actions on its website.
The TGA collects intelligence in relation to alleged breaches of the Therapeutic Goods Act 1989 and Regulations and undertakes:
- criminal prosecutions (in association with the Commonwealth Director of Public Prosecutions) and
- civil litigation for the recovery of civil penalties where appropriate.
2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
2024
- Court proceedings initiated for alleged unlawful import, supply and representations made of rapid antigen test kits
TGA has commenced proceedings in the Federal Court of Australia against Key Promotional Products Pty Ltd, and an individual, for allegedly importing and supplying unapproved rapid antigen test kits - Individual sentenced for offences against the Therapeutic Goods Act
The director of Elite Labs Pty Ltd was sentenced to 2 years imprisonment for his role in the unlawful manufacture, supply, advertising and export of performance and image enhancing therapeutic goods. - Court proceedings initiated against Montu Group Pty Ltd, Alternaleaf Pty Ltd, and an individual for alleged unlawful advertising of medicinal cannabis
We have commenced proceedings in the Federal Court of Australia against Montu Group Pty Ltd, its subsidiary Alternaleaf Pty Ltd and their common director for alleged unlawful advertising of medicinal cannabis on websites and social media pages.
2023
- Court proceedings initiated against CDA Clinics QLD Pty Ltd and its former director for alleged unlawful advertising of medicinal cannabis
We have alleged that the advertising on the company's website and social media was unlawful because medicinal cannabis products are prescription-only medicines that can't be advertised directly to consumers. - Vapor Kings Pty Ltd and a Director penalised a total of $5 million for advertising nicotine vaping products
The Federal Court of Australia has ordered Vapor Kings Pty Ltd to pay $4.9 million for unlawfully advertising nicotine vaping products. A company Director was also ordered to pay $100,000 in penalties. - Notice published pursuant to an order of the Federal Court of Australia
A delegate of the Secretary, Department of Health and Aged Care made a decision under s 61(5C) of the Therapeutic Goods Act 1989 to release certain information. The Federal Court determined that the release of information was not authorised by s 61(5C). - Company director sentenced to 2 years imprisonment with personal and company fines of over $2.5 million for selling illegal SARMs
Christopher Ramsey, the Director of AusLabs, Smart Labs and iSARMs, has been sentenced 2 years imprisonment and fined $300,000 for his role in the manufacture, supply and advertising of illegal Selective Androgen Receptor Modulators and nootropic products. Mr Ramsey’s three companies also received significant fines totalling $2,225,000.
2022
- Aus Labs, Smart Labs, iSARMs and Director Christopher Ramsey plead guilty to over 200 charges for illegal manufacture, supply and advertising of SARMs and nootropics
On 25 October 2022, Natural Franchises Pty Ltd pleaded guilty in a Sydney court to over 200 offences of the Therapeutic Goods Act 1989 for the manufacture, supply and advertising of unapproved therapeutic goods. - Court proceedings initiated against Vapor Kings Pty Ltd and its director for alleged unlawful advertising of nicotine vaping products
The TGA has commenced Federal Court proceedings against Vapor Kings Pty Ltd and its sole director for alleged unlawful advertising of nicotine vaping products. - Court proceedings initiated against Prefixx Pty Ltd and its director for alleged unlawful advertising of nicotine vaping products
The TGA has commenced court proceedings against Prefixx Pty Ltd and its sole director, Mr Brad Anthonisz, for alleged unlawful advertising of nicotine vaping products. - FuturePro Pty Ltd and its Director convicted and sentenced for unlawful conduct relating to alternative medicines
FuturePro was convicted and released on recognisance, its directior was convicted and fined $25,000. - FuturePro Pty Ltd and its Director pleads guilty to illegal health claims and supply of bloodroot and gumby gumby alternative medicines
Gold Coast company FuturePro Pty Ltd, trading as Inet Herbal, has pleaded guilty to seven breaches of the Therapeutic Goods Act 1989.
2021
- Oxymed Australia Pty Ltd and director Malcolm Hooper ordered to pay $3 million for unlawful advertising of hyperbaric oxygen therapy devices
Outcomes of the court action against Oxymed Australia Pty Ltd - Court convicts HealthHub247 Pty Ltd and its Director for sports supplements offences
HealthHub247 Pty Ltd (HealthHub247) and its Director have been convicted of the unlawful manufacture, counterfeit, advertising and supply of sports supplements that contain prohibited substances in the current Poisons Standard. - Evolution Supplements Australia and its Director penalised total of $12 million for advertising illegal sports supplements
The Federal Court of Australia has ordered Evolution Supplements Australia and its Director to pay $12 million
2020
- Conviction for unlawful importation of cosmetic injectables following unpaid fines
On 9 December 2020, the Magistrates' Court of Victoria convicted the woman on three charges of unlawful importation of therapeutic goods. - Conviction for unlawful advertising of sports supplements
On 29 July 2020, the ACT Magistrates Court convicted the former owner of a Canberra-based sports supplements company on four charges of unlawful advertising of therapeutic goods. - Court proceedings commenced against HEALTHHUB247 and its director for alleged illegal activity relating to performance enhancing drugs
Criminal court proceedings have been initiated in response to alleged breaches of the Therapeutic Goods Act 1989 by Brisbane-based company HEALTHHUB247 PTY LTD and its director. - TGA initiates court proceedings against Oxymed Australia and director Malcolm Hooper for alleged unlawful advertising
The TGA has initiated proceedings in the Federal Court of Australia in response to alleged unlawful advertising of hyperbaric oxygen therapy chambers by Oxymed Australia and its sole director, Mr Malcolm Hooper. - Federal Court restrains MMS Australia from advertising and supplying MMS and DMSO
The Federal Court of Australia has made orders restraining MMS Australia from advertising and supplying goods containing certain potentially dangerous substances, including the main chemical used to make 'Miracle Mineral Solution' (MMS), until a further hearing next week. - TGA initiates court proceedings against MMS Australia and director Charles Barton for alleged unlawful advertising
The TGA has initiated proceedings in the Federal Court of Australia in response to the alleged unlawful advertising of Miracle Mineral Supplement (MMS), dimethyl sulfoxide (DMSO) and other medicines by Southern Cross Directories Pty Ltd trading as MMS Australia. - Federal Court of Australia grants interim injunction to prevent advertising by Evolution Supplements Australia
The Federal Court of Australia (Federal Court) has granted an interim injunction to prevent Evolution Supplements Australia Pty Ltd (Evolution Supplements Australia) and its sole director, Mr Cumhur Keskin, from advertising specified therapeutic goods. - Court proceedings commenced against Evolution Supplements Australia and its sole director for alleged advertising breaches
The Secretary of the Department of Health has commenced proceedings in the Federal Court of Australia against Evolution Supplements Australia Pty Ltd (trading as Evolution Supplements Australia) and Mr Cumhur Keskin, the sole director and secretary of the company, for alleged breaches of the Therapeutic Goods Act 1989.